Menu Back to Committee

Meet the Program Commitee for 2021!

Program Committee

  • Magda  Chlebus, MA
    Magda Chlebus, MA Executive Director, Science Policy & Regulatory Affairs
    EFPIA, Belgium
  • Inaki  Gutierrez-Ibarluzea
    Inaki Gutierrez-Ibarluzea Director of organizational innovation and management
    BIOEF, Spain
  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Esa Henrik Heinonen, DrMed
    Esa Henrik Heinonen, DrMed Director, Assessment of Medicinal Products
    Finnish Medicines Agency (Fimea), Finland
  • Claire  Hill-Venning, PhD
    Claire Hill-Venning, PhD Senior Director Regulatory Policy
    Janssen, United Kingdom
  • Hubert  Leufkens, PharmD, PhD
    Hubert Leufkens, PharmD, PhD Professor, Pharmaceutical Policy and Regulatory Science
    Utrecht University, Netherlands
  • Alexander  Natz, JD
    Alexander Natz, JD Secretary General
    European Confederation of Pharmaceutical Entrepreneurs, Belgium
  • Lorraine  Nolan, PhD
    Lorraine Nolan, PhD Chief Executive
    Health Products Regulatory Authority (HPRA), Ireland
  • Susanne  Ausborn, PhD
    Susanne Ausborn, PhD Global Head International Regulatory Policy
    F. Hoffmann-La Roche Ltd., Switzerland
  • Andrew  Bate, PhD, MA
    Andrew Bate, PhD, MA VP, Head of Safety Innovation & Analytics
    GlaxoSmithKline, United Kingdom
  • Simon  Bennett, MSc
    Simon Bennett, MSc Director, EU Regulatory Policy
    Biogen, United Kingdom
  • Susan  Bhatti, PhD
    Susan Bhatti, PhD Director EU Global Scientific and Regulatory Policy
    Merck Kgaa, Germany
  • Patrick  Brady, PharmD
    Patrick Brady, PharmD Vice President, Regulatory Affairs Head, Regulatory Policy and Intelligence
    Bayer AG Pharmaceuticals, Germany
  • Gabriele  Braeunlich, PhD
    Gabriele Braeunlich, PhD VP, Head Regulatory Affairs Strategy
    Bayer AG, Germany
  • Mireille  Collombat, PharmD
    Mireille Collombat, PharmD Senior Director Group Leader, Global Drug Regulatory Affairs
    Actelion Pharmaceuticals Ltd., Switzerland
  • Emma  Du Four, MBA
    Emma Du Four, MBA Head of International Regulatory Policy
    Abbvie, United Kingdom
  • Benjamin  Horbach, MSc
    Benjamin Horbach, MSc Health Systems Strategy Leader - Personalised Healthcare
    F. Hoffmann-La Roche, Switzerland
  • Jürgen  Kübler, PhD
    Jürgen Kübler, PhD Owner
    Quantitative Scientific Consulting, Germany
  • Frank  Montgomery, PhD
    Frank Montgomery, PhD Global Head Regulatory CMC, GRAPSQA
    AstraZeneca, United Kingdom
  • Paolo  Morgese, MSc
    Paolo Morgese, MSc Director, EU Market Access and Member Relations
    Alliance for Regenerative Medicine (ARM), Belgium
  • Mireille  Muller, DrSc, PhD, MSc
    Mireille Muller, DrSc, PhD, MSc Regulatory Policy & Intelligence Director
    Novartis Pharma AG, Switzerland
  • Dolores  Hernan Perez de la Ossa, PhD
    Dolores Hernan Perez de la Ossa, PhD Quality Specialist - Pharmaceutical Quality Office
    European Medicines Agency, Netherlands
  • Gavin  Outteridge, MA
    Gavin Outteridge, MA Managing Director
    AESARA Europe, United Kingdom
  • Florence  Roizard, PharmD
    Florence Roizard, PharmD Associate Vice President Regulatory Affairs
    MSD, France
  • Oliver  Sude, PhD
    Oliver Sude, PhD Legal Counsel, EU Affairs
    European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Belgium
  • Hans  van Bruggen, MSc
    Hans van Bruggen, MSc CEO and Senior RA Consultant
    Qdossier, Netherlands
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Exec. Director International World Wide Patient Safety, Europe
    Bristol-Myers Squibb, Switzerland
  • Andrew  Thomson, PhD, MA, MS
    Andrew Thomson, PhD, MA, MS Statistician, Methodology Taskforce
    European Medicines Agency, Netherlands
Load More